amylin
Amycretin tracker
Educational reference for Amycretin. Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
—
Tmax
—
Category
amylin
Also known as: amycretin-sc, amycretin-oral
Amycretin is an investigational amylin and GLP-1 receptor co-agonist.
Mechanism
An investigational single-molecule agonist of both the amylin and GLP-1 receptors, in subcutaneous and oral forms.
Research summary
Phase 1b/2a data for the subcutaneous form were published in The Lancet in 2025. Not FDA-approved.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- Amycretin phase 1b/2a subcutaneous trial · The Lancet (2025)No verified human half-life was located in public summaries, so none is shown.
TrackPep adalah aplikasi pencatatan. Aplikasi ini merekam apa yang Anda catat dan tidak pernah merekomendasikan atau menghitung jumlahnya.